Live Attenuated

Also written as LAIV.

Live attenuated vaccines are contraindicated in patients with primary immunodeficiencies primarily because of:

What our notes say

Live attenuated vaccines are contraindicated in patients with primary immunodeficiencies primarily because of: (Immunopathology Cat: Hypersensitivity & Anaphylaxis MCQs)
Towne strain is a candidate live attenuated vaccine, but concerns exist about latency/reactivation (Mycology Revision: Fungal Infections, Histoplasmosis & Cryptococcosis)
Live attenuated 17D vaccine, single dose, long-lasting immunity (Medical Virology & Mycology Paper Two 2022/2023 — MKU MBMM 3300 Questions & Answ)
Live attenuated 17D vaccine gives long-lasting, essentially lifelong immunity after a single dose (Medical Virology CAT 2024/2025 — MKU MBMM 3333 Questions & Answers)
A patient with selective IgA deficiency receiving LAIV (Live Attenuated Influenza Vaccine) may experience: (Immunopathology Cat: Hypersensitivity & Anaphylaxis MCQs)
Live attenuated – weakened pathogen, strong/long-lasting immunity, contraindicated in immunocompromised/pregnancy (e.g. (Pharmacology CRASH Course)